Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
Recruiting now · Phase 1
Conditions studied: BPH (Benign Prostatic Hyperplasia)
In brief
This study is a double blinded RCT with pre-post test design on the effect of combination of dutasteride and aloe vera, compared to dutasteride only, on uroflowmetry results, prostate volume, and VEGF serum level among patients with benign prostate hyperplasia. The treatment was given for 12 weeks
Key facts
- Study ID
- NCT07065682
- Run by
- Universitas Diponegoro
- People needed
- 84
- Starts
- 2023-07-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-07-15
Who can join
Age: 50 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with BPH clinically or radiologically (prostate volume > 30 gram, Qmax <15 mL/s)
- Willing to participate to the study
You may not qualify if…
- Clinically or radiologically suspected of having prostatic cancer
- Previous prostatic surgery
- Patients with urinary retention
- Patients with BPH complications: urinary tract infections, urolithiasis, or hydroneprhosis
- Previously consumed alpha blocker or 5ARI in the last 6 months
- Have consumed aloe vera extract routinely
Where it is running
- RSUD Karawang — Karawang, West Java, Indonesia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.